CENTA
Central Garden & Pet Company NASDAQ Listed Feb 6, 2007$37.78
+2.25%
vs $36.95
Mkt Cap $2.7B
52w Low $25.97
92.3% of range
52w High $38.76
50d MA $34.64
200d MA $31.64
P/E (TTM)
14.8x
EV/EBITDA
7.6x
P/B
1.5x
Debt/Equity
0.9x
ROE
9.9%
P/FCF
8.3x
RSI (14)
75.30
ATR (14)
$0.97
Beta
0.54
50d MA
$34.64
200d MA
$31.64
Avg Volume
344.8K
Central Garden & Pet Company produces and distributes various products for the lawn and garden, and pet supplies markets in the United States. It operates through two segments, Pet and Garden. The Pet segment provides dog and cat supplies, such as dog treats and chews, toys, pet beds and grooming products, waste management and training pads, and pet containment; supplies for aquatics, small animals, reptiles, and pet birds, including toys, cages and habitats, bedding, and food and supplements; animal and household health and insect control products; live fish and products for fish, reptiles, and other aquarium-based pets, such as aquariums, furniture and lighting fixtures, pumps, filters, water conditioners, food, and supplements; and products for horses and livestock, as well as outdoor cushions and pillows. This segment sells its products under the Aqueon, Cadet, Comfort Zone, Farnam, Four Paws, Kaytee, K&H Pet Products, Nylabone, and Zilla brands. The Garden segment offers lawn and garden supplies products that include grass seed; wild bird feed, bird feeders, bird houses, and other birding accessories; fertilizers; decorative outdoor lifestyle products; live plants; and weed and grass, as well as other herbicides, insecticide, and pesticide products. This segment sells its lawn and garden supplies products under the AMDRO, Ferry-Morse, Pennington, and Sevin brands, as well as under Bell Nursery, Lilly Miller, and Over-N-Out other brand names. Central Garden & Pet Company was founded in 1955 and is based in Walnut Creek, California.
1340 Treat Boulevard · Walnut Creek, CA 94597 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | AMC | 1.08 | 1.29 | +19.4% | 33.66 | +4.2% | +3.2% | -1.4% | -0.1% | +0.5% | -0.1% | — |
| Feb 4, 2026 | AMC | 0.11 | 0.21 | +90.9% | 31.81 | -2.9% | +4.3% | +2.7% | -1.8% | +0.9% | -0.7% | — |
| Nov 24, 2025 | AMC | -0.20 | -0.09 | +55.0% | 28.59 | +6.8% | +8.2% | +0.2% | -0.1% | -1.4% | +0.0% | — |
| Aug 6, 2025 | AMC | 1.34 | 1.56 | +16.4% | 35.74 | +0.3% | -11.2% | -3.2% | -0.8% | +4.7% | +4.9% | — |
| May 7, 2025 | AMC | 0.94 | 1.04 | +10.6% | 30.21 | +0.1% | +0.3% | +0.7% | +4.1% | +1.0% | -3.8% | — |
| Feb 5, 2025 | AMC | -0.03 | 0.21 | +800.0% | 31.69 | +7.0% | +7.9% | -3.9% | -0.0% | +2.4% | -2.2% | — |
| Nov 25, 2024 | AMC | -0.22 | -0.18 | +18.2% | 33.22 | -3.2% | +1.6% | +1.1% | -1.0% | +2.8% | -1.3% | — |
| Aug 7, 2024 | AMC | 1.20 | 1.32 | +10.0% | 32.70 | -2.9% | +5.7% | -3.0% | -0.9% | -0.3% | -1.0% | — |
| May 8, 2024 | AMC | 0.76 | 0.99 | +30.3% | 35.94 | -0.5% | +11.3% | +0.6% | -0.4% | -0.1% | +2.0% | — |
| Feb 7, 2024 | AMC | -0.14 | 0.01 | +107.1% | 32.97 | +0.9% | +5.1% | +3.6% | +6.2% | -4.0% | +1.7% | — |
| Nov 20, 2023 | AMC | 0.06 | 0.08 | +33.3% | 32.08 | -3.9% | -10.7% | +0.1% | +0.7% | -0.3% | +0.7% | — |
| Aug 2, 2023 | AMC | 1.16 | 1.40 | +20.7% | 30.34 | +5.8% | +13.4% | -1.2% | +0.7% | +0.3% | +0.1% | — |
| May 3, 2023 | AMC | 0.95 | 0.90 | -5.3% | 27.87 | +1.5% | +6.8% | +0.2% | -2.5% | -1.8% | +0.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17 | JP Morgan | Maintains | Underweight → Underweight | — | $33.98 | $34.27 | +0.9% | +2.5% | +0.2% | -1.3% | -1.8% | +1.1% |
| Jan 16 | JP Morgan | Downgrade | Neutral → Underweight | — | $30.14 | $29.11 | -3.4% | -2.9% | -1.4% | +1.7% | +0.5% | -0.9% |
| Nov 25 | JP Morgan | Maintains | Neutral → Neutral | — | $28.59 | $30.54 | +6.8% | +8.2% | +0.2% | -0.1% | -1.4% | +0.0% |
| Oct 23 | JP Morgan | Maintains | Neutral → Neutral | — | $28.33 | $28.26 | -0.2% | +1.2% | +1.2% | +0.8% | +0.3% | -3.9% |
| Aug 7 | Canaccord Genuity | Maintains | Buy → Buy | — | $35.74 | $35.83 | +0.3% | -11.2% | -3.2% | -0.8% | +4.7% | +4.9% |
| Apr 30 | Truist | Downgrade | Buy → Hold | — | $30.48 | $30.80 | +1.0% | -3.0% | +0.7% | +1.6% | +2.4% | -2.2% |
| Apr 11 | JP Morgan | Maintains | Neutral → Neutral | — | $31.35 | $31.06 | -0.9% | +1.2% | +1.9% | -0.2% | -4.2% | -0.3% |
| Jan 16 | JP Morgan | Maintains | Neutral → Neutral | — | $30.49 | $30.38 | -0.4% | +1.1% | -0.4% | +2.4% | -2.2% | +1.5% |
| Jan 7 | Argus | Downgrade | Buy → Hold | — | $31.97 | $31.27 | -2.2% | -4.8% | +0.6% | -2.5% | +3.1% | -1.2% |
| Oct 11 | JP Morgan | Maintains | Neutral → Neutral | — | $28.56 | $28.54 | -0.1% | +3.0% | +2.1% | -0.3% | +2.7% | -1.4% |
| Aug 8 | JP Morgan | Maintains | Neutral → Neutral | — | $32.70 | $31.75 | -2.9% | +5.7% | -3.0% | -0.9% | -0.3% | -1.0% |
| Jul 22 | JP Morgan | Maintains | Neutral → Neutral | — | $33.66 | $33.80 | +0.4% | +0.7% | -2.2% | +0.4% | +0.8% | +1.6% |
| May 13 | Truist | Maintains | Buy → Buy | — | $40.23 | $40.25 | +0.0% | -0.4% | -0.1% | +2.0% | -3.0% | +0.3% |
| Feb 9 | Truist | Maintains | Buy → Buy | — | $34.65 | $39.55 | +14.1% | +3.6% | +6.2% | -4.0% | +1.7% | +0.1% |
| Feb 8 | JP Morgan | Maintains | Neutral → Neutral | — | $32.97 | $33.28 | +0.9% | +5.1% | +3.6% | +6.2% | -4.0% | +1.7% |
| Sep 20 | Truist | Maintains | Buy → Buy | — | $33.79 | $33.97 | +0.5% | +0.4% | +0.2% | -0.6% | -1.4% | -2.6% |
| Aug 3 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $30.34 | $32.10 | +5.8% | +13.4% | -1.2% | +0.7% | +0.3% | +0.1% |
| Apr 18 | JP Morgan | Maintains | Neutral → Neutral | — | $30.79 | $30.82 | +0.1% | -1.1% | -7.1% | +1.4% | -1.4% | +1.7% |
| Apr 18 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $30.79 | $30.82 | +0.1% | -1.1% | -7.1% | +1.4% | -1.4% | +1.7% |
| Apr 18 | Truist | Maintains | Buy → Buy | — | $30.79 | $30.82 | +0.1% | -1.1% | -7.1% | +1.4% | -1.4% | +1.7% |
| Jan 12 | JP Morgan | Maintains | Overweight → Overweight | — | $29.84 | $29.98 | +0.5% | +0.6% | +2.1% | -0.2% | -0.7% | +0.0% |
| Nov 21 | JP Morgan | Maintains | Neutral → Neutral | — | $33.45 | $33.43 | -0.1% | +0.3% | -8.8% | -0.6% | +0.1% | +0.5% |
| Nov 21 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $33.45 | $33.43 | -0.1% | +0.3% | -8.8% | -0.6% | +0.1% | +0.5% |
| Oct 12 | JP Morgan | Maintains | Neutral → Neutral | — | $28.15 | $28.17 | +0.1% | -1.0% | +0.3% | +0.1% | +3.2% | +1.2% |
| Aug 25 | CJS Securities | Maintains | Market Outperform → Outperform | — | $32.12 | $32.44 | +1.0% | +2.2% | -2.3% | -1.2% | -2.3% | -2.5% |
| Aug 7 | Truist | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Aug 3 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $32.72 | $32.50 | -0.7% | -0.9% | +1.6% | +0.8% | +1.6% | -3.7% |
| Jun 22 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $31.38 | $30.99 | -1.2% | +1.3% | +2.0% | +0.1% | -0.2% | -4.6% |
| Nov 29 | Argus | Downgrade | Buy → Hold | — | $36.50 | $36.67 | +0.5% | -2.7% | -2.4% | -1.2% | +3.6% | +1.4% |
| May 13 | Argus | Upgrade | Hold → Buy | — | $40.89 | $41.04 | +0.4% | +3.2% | +1.0% | -1.5% | -2.1% | -0.4% |
| May 10 | Truist | Maintains | Buy → Buy | — | $43.63 | $43.90 | +0.6% | -1.1% | -0.3% | -5.0% | +3.2% | +1.0% |
| May 5 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $40.91 | $40.88 | -0.1% | +4.1% | +2.0% | +0.5% | -1.1% | -0.3% |
| Apr 11 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | — | — | — | — | — | — | — | — |
| Mar 23 | Truist | Upgrade | Hold → Buy | — | $38.17 | $37.84 | -0.9% | -2.3% | +1.2% | +2.2% | +5.0% | +0.2% |
| Feb 4 | KeyBanc | Maintains | Overweight → Overweight | — | $32.74 | $36.01 | +10.0% | +1.5% | +0.1% | +2.0% | +3.8% | -3.4% |
| Feb 3 | KeyBanc | Maintains | Overweight → Overweight | — | $31.94 | $31.90 | -0.1% | +2.5% | +1.5% | +0.1% | +2.0% | +3.8% |
| Feb 3 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $31.94 | $31.90 | -0.1% | +2.5% | +1.5% | +0.1% | +2.0% | +3.8% |
| Aug 6 | KeyBanc | Maintains | Overweight → Overweight | — | $29.22 | $31.99 | +9.5% | +7.5% | -0.6% | -0.1% | +0.0% | +1.9% |
| Aug 5 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $29.33 | $29.35 | +0.1% | -0.4% | +7.5% | -0.6% | -0.1% | +0.0% |
| Aug 3 | KeyBanc | Maintains | Overweight → Overweight | — | $27.72 | $28.00 | +1.0% | +5.1% | +0.7% | -0.4% | +7.5% | -0.6% |
| Aug 2 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | — | — | — | — | — | — | — | — |
| May 13 | SunTrust Robinson Humphrey | Maintains | Hold → Hold | — | $26.59 | $26.45 | -0.5% | -2.9% | -0.1% | +0.2% | +5.3% | -3.8% |
| May 7 | KeyBanc | Maintains | Overweight → Overweight | — | $24.51 | $24.59 | +0.3% | +4.4% | +2.3% | +1.2% | +0.3% | -2.9% |
| May 6 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $24.46 | $24.86 | +1.6% | +0.2% | +4.4% | +2.3% | +1.2% | +0.3% |
| May 6 | SunTrust Robinson Humphrey | Maintains | Hold → Hold | — | $24.46 | $24.86 | +1.6% | +0.2% | +4.4% | +2.3% | +1.2% | +0.3% |
| Mar 17 | BofA Securities | Upgrade | Neutral → Buy | — | $20.11 | $20.42 | +1.5% | +11.7% | -4.6% | +5.6% | -20.3% | +3.5% |
| Feb 6 | KeyBanc | Maintains | Overweight → Overweight | — | $24.02 | $25.22 | +5.0% | -2.7% | -3.1% | +0.7% | -0.4% | +0.3% |
| Feb 5 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $23.70 | $23.91 | +0.9% | +1.4% | -2.7% | -3.1% | +0.7% | -0.4% |
| Feb 5 | SunTrust Robinson Humphrey | Maintains | Hold → Hold | — | $23.70 | $23.91 | +0.9% | +1.4% | -2.7% | -3.1% | +0.7% | -0.4% |
| Nov 27 | KeyBanc | Maintains | Overweight → Overweight | — | $23.74 | $19.42 | -18.2% | -17.4% | +2.0% | +1.4% | +2.3% | +0.3% |
No insider trades available.
8-K · 5.02
!!! Very High
Central Garden & Pet Company -- 8-K 5.02: Executive Change
Central Garden & Pet Company appointed Kay M. Schwichtenberg as Executive Vice President effective March 1, 2026, signaling management strengthening in a key leadership position.
Feb 18
8-K
Central Garden & Pet Company -- 8-K Filing
Central Garden & Pet attributed first-quarter revenue pressure to strong prior-year comparisons and shipment timing shifts to Q2, potentially indicating sequential improvement ahead.
Feb 4
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Portfolio Management Llc | 3,424,678 | $111M | New | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 2,093,302 | $68M | New | Mar 2026 |
| 3 | Allspring Global Investments Holdings, Llc | 1,770,073 | $57M | Reduced | Mar 2026 |
| 4 | Victory Capital Management Inc | 1,591,138 | $52M | Reduced | Mar 2026 |
| 5 | Westwood Holdings Group Inc | 1,217,619 | $36M | Added | Dec 2025 |
| 6 | Morgan Stanley | 988,104 | $29M | Added | Dec 2025 |
| 7 | Qube Research & Technologies Ltd | 548,325 | $18M | Added | Mar 2026 |
| 8 | First Eagle Investment Management, Llc | 520,876 | $17M | Added | Mar 2026 |
| 9 | Northern Trust Corp | 503,753 | $16M | Added | Mar 2026 |
| 10 | Two Sigma Investments, Lp | 498,669 | $16M | Added | Mar 2026 |
| 11 | Renaissance Technologies Llc | 453,875 | $15M | Reduced | Mar 2026 |
| 12 | Bank Of America Corp /de/ | 449,597 | $15M | Added | Mar 2026 |
| 13 | William Blair Investment Management, Llc | 374,991 | $12M | Added | Mar 2026 |
| 14 | Bank Of New York Mellon Corp | 342,049 | $11M | Reduced | Mar 2026 |
| 15 | Invesco Ltd. | 293,967 | $10M | Added | Mar 2026 |
| 16 | Aqr Capital Management Llc | 269,069 | $9M | Reduced | Mar 2026 |
| 17 | Principal Financial Group Inc | 283,535 | $8M | Added | Dec 2025 |
| 18 | Universal- Beteiligungs- Und Servicegesellschaft Mbh | 240,415 | $8M | Added | Mar 2026 |
| 19 | Tudor Investment Corp | 216,007 | $7M | New | Mar 2026 |
| 20 | Jpmorgan Chase & Co | 209,937 | $7M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$2.70B
Enterprise Value
$2.72B
P/E (TTM)
14.82x
Forward P/E
13.28x
PEG Ratio
0.22x
P/B
1.50x
P/S
0.77x
P/FCF
8.28x
EV/EBITDA
7.57x
Shares Out
63.8M
Financials (TTM)
Revenue
$3.13B
Net Income
$162.8M
EBITDA
$359.3M
Free Cash Flow
$291.1M
Op Cash Flow
$332.5M
EPS Basic
$2.58
EPS Diluted
$2.55
EPS Forward
$2.84
Gross Margin
31.1%
Op Margin
8.5%
Net Margin
5.2%
Balance Sheet
Total Assets
$3.63B
Total Liab.
$2.04B
Total Equity
$1.58B
Cash
$882.5M
LT Debt
$1.19B
Book Value/Sh
$25.12
Debt/Equity
0.91x
Current Ratio
3.67
Quick Ratio
2.33
Returns & Growth
ROE
9.9%
ROA
4.3%
ROIC
6.4%
Rev Growth YoY
-2.2%
EPS Growth YoY
+57.3%
Price Returns
2W
+0.4%
1M
+1.7%
3M
-1.2%
6M
+10.3%
12M
+6.8%
Technicals
52W High
$38.76
52W Low
$25.97
50d MA
$34.64
200d MA
$31.64
RSI (14)
75.30
ATR (14)
$0.97
Beta
0.54
Avg Volume
345K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$50.00
High
$50.00
Low
$50.00
Median
$50.00
Data updated apr 25, 2026 12:42am
· Source: financialmodelingprep.com